Table 1.
Antimicrobial resistance rate (%) of Uu infection in patients
| 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| Case (%) | Case (%) | Case (%) | Case (%) | Case (%) | |
| TET | 12 (6.1) | 37 (6.9) | 39 (6.0) | 44 (11.9) | 176 (6.9) |
| LEV | 12 (6.1) | 31 (5.8) | 19 (2.9) | 34 (4.5) | 161 (6.3) |
| ERY | 25 (12.6) | 128 (23.9) | 87 (13.4) | 164 (21.5) | 267 (10.5) |
| JOS | 1 (0.5) | 2 (0.4) | 0 (0.0) | 0 (0.0) | 5 (0.2) |
| DOX | 9 (4.5) | 26 (4.9) | 22 (3.4) | 25 (3.3) | 117 (4.6) |
| CIP | 126 (63.6) | 396 (73.9) | 480 (73.8) | 589 (77.1) | 1881 (73.8) |
| OFX | 11 (5.6) | 27 (5.0) | 21 (3.2) | 44 (5.8) | 89 (3.5) |
| MIN | 9 (4.5) | 25 (4.7) | 21 (3.2) | 25 (3.3) | 104 (4.1) |
| ROX | 12 (6.1) | 53 (9.9) | 29 (4.5) | 86 (11.3) | 114 (4.5) |
| AZM | 10 (5.1) | 32 (6.0) | 10 (1.5) | 26 (3.4) | 58 (2.3) |
| CLR | 9 (4.5) | 26 (4.9) | 11 (1.7) | 25 (3.3) | 54 (2.1) |
| SPA | 15 (7.6) | 89 (16.6) | 76 (11.7) | 195 (25.5) | 261 (10.2) |
| n | 198 | 536 | 650 | 764 | 2550 |
Abbreviations: AZM, azithromycin; CIP, ciprofloxacin; CLR, clarithromycin; DOX, doxycycline; ERY, erythromycin; JOS, josamycin; LEV, levofloxacin; MIN, minocycline; OFX, ofloxacin; ROX, roxithromycin; SPA, sparfloxacin; TET, tetracycline; Uu, Ureaplasma urealyticum.